Ricerca avanzata

Matthew E.
McManus served as Chairman at Bluestone Real Estate Capital LLC.
He received his undergraduate degree from St. Lawrence University in 1991.

Matthew F.
McManus is currently the Chairman at Ansa Biotechnologies, Inc. since 2023 and the Chief Operating Officer at Bio-Techne Corp.
since 2024.
Previously, he served as the President, Chief Executive Officer & Director at PrimeraDx, Inc. from 2010 to 2014.
He then held the position of President, Chief Executive Officer & Director at Asuragen, Inc. from 2014 to 2021.
Before that, he worked as a Manager-Business Unit at Procter & Gamble Co. He also served as the Chief Operating Officer & Executive Vice President at Azenta, Inc. in 2022.
Additionally, he worked as a Management Consultant at McKinsey & Co., Inc. and as a Medical Scientist at Novartis Institutes for Biomedical Research, Inc. He started his career as the COO-Pathology and Laboratory Medicine Institute at The Cleveland Clinic Foundation from 2007 to 2010.
Dr. McManus completed his undergraduate degree at the College of the Holy Cross (Massachusetts) and holds an MBA from Boston College.
He also obtained a doctorate degree from the University of Pennsylvania Medical Center.

Joseph P.
McManus is currently the Director at Associated Services for the Blind & Visually Impaired.
He was previously the Senior Vice President at Thomas Properties Group, Inc. He received his undergraduate degree from The Pennsylvania State University in 1977.

Victoria McManus formerly worked at Greenbrier Cos., Inc., as Chief Strategic Officer & Executive VP from 2015 to 2017, Babcock & Brown LP, as Partner, CIT Global, Inc., as President-Rail Division, Babcock & Brown Rail Management LLC, as President in 2008, and Babcock & Brown Freight Management LLC, as President in 2008.